Screener
Ocular Therapeutix OCUL Shares (Diluted)
Shares (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Ocular Therapeutix in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.
The source filing: Ocular Therapeutix’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 7:28 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001104659-26-055256
| Line item | Three Months Ended / March 31, 2026 | Three Months Ended / March 31, 2025 |
|---|---|---|
| Interest expense | (2,777) | (2,984) |
| Change in fair value of derivative liabilities | 1,455 | (978) |
| Total other income (expense), net | 4,728 | (136) |
| Net loss | $(88,612) | $(64,053) |
| Net loss per share, basic | $(0.40) | $(0.38) |
| Weighted average common shares outstanding, basic | 224,099,410 | 169,396,989 |
| Net loss per share, diluted | $(0.40) | $(0.38) |
| Weighted average common shares outstanding, diluted | 224,099,410 | 169,396,989 |
Item 1. Financial Statements (unaudited)
FAQ
- What is Ocular Therapeutix's shares (diluted)?
- Ocular Therapeutix (OCUL) reported shares (diluted) of 224.1M in Q1 2026.
- How has Ocular Therapeutix's shares (diluted) changed year-over-year?
- Ocular Therapeutix's shares (diluted) increased by 32.3% year-over-year, from 169.4M to 224.1M.
- What is the long-term trend for Ocular Therapeutix's shares (diluted)?
- Over 4 years (2021 to 2025), Ocular Therapeutix's shares (diluted) has grown at a 20.6% compound annual growth rate (CAGR), from 336.9M to 713.2M.
- What does shares (diluted) mean?
- The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.
Ask your AI about Ocular Therapeutix's shares (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude